Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
D000230:Adenocarcinoma / Q000188:drug therapy; D000577:Amides / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000188:drug therapy*; D011374:Progesterone / Q000627:therapeutic use; D012004:Rectal Neoplasms / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use; D014226:Triazenes / Q000627:therapeutic use
D000577:Amides; D000728:Androgens; D004967:Estrogens; D005938:Glucocorticoids; D007093:Imidazoles; D014226:Triazenes; D011374:Progesterone; D008466:Mechlorethamine; D003520:Cyclophosphamide; D013852:Thiotepa; D005472:Fluorouracil; D008727:Methotrexate